SEC Comment Letter for InspireMD, Inc. (NSPR) (CIK 0001433607) (NSPR) — Jan 23, 2012

InspireMD, Inc. (NSPR) (CIK 0001433607)
Date: Jan. 23, 2012 · CIK: 0001433607 · Accession: 0000000000-12-003682

View on Edgar

AI Filing Summary & Sentiment

Sentiment

Urgency

Document Type

Confidence

SEC Posture

Company Posture

Summary

Reasoning

File numbers found in text: 333-162168

Date

January 23, 2012

Author

Amanda Ravitz

Form

UPLOAD

Company

InspireMD, Inc. (NSPR) (CIK 0001433607)

Letter

January 23, 2012 Via E-mail Ofir Paz Chief Executive Officer InspireMD, Inc. 3 Menorat Hamaor St. Tel Aviv, Israel 67448 Re: InspireMD, Inc. f/k/a Saguaro Resources, Inc. Form 10-K for the fiscal year ended June 30, 2010 Filed August 17, 2010 File No. 333-162168

Dear Mr. Paz:

We have completed our review of your f iling. We remind you that our comments or changes to disclosure in res ponse to our comments do not for eclose the Commission from taking any action with respect to the company or th e filing and the company may not assert staff comments as a defense in any proceeding ini tiated by the Commission or any person under the federal securities laws of the United States. We urge all pers ons who are responsible for the accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the information the Securities Exchange Act of 1934 and all applicable rules require. Sincerely,

/s/ Daniel Morris for Amanda Ravitz Assistant Director

cc (via e-mail): Rick A. Werner, Esq.

Show Raw Text

January 23, 2012
 Via E-mail

Ofir Paz Chief Executive Officer InspireMD, Inc. 3 Menorat Hamaor St. Tel Aviv, Israel 67448
Re: InspireMD, Inc. f/k/a Saguaro Resources, Inc.
 Form 10-K for the fiscal year ended June 30, 2010  Filed August 17, 2010
File No. 333-162168

Dear Mr. Paz:

We have completed our review of your f iling.  We remind you that our comments or
changes to disclosure in res ponse to our comments do not for eclose the Commission from taking
any action with respect to the company or th e filing and the company may not assert staff
comments as a defense in any proceeding ini tiated by the Commission or any person under the
federal securities laws of the United States.  We urge all pers ons who are responsible for the
accuracy and adequacy of the disclosure in the fi ling to be certain that the filing includes the
information the Securities Exchange Act of 1934 and all applicable rules require.
  Sincerely,

             /s/  Daniel Morris for
  Amanda Ravitz  Assistant Director

 cc (via e-mail): Rick A. Werner, Esq.

SecProbe.io